Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Price Website For Part D Could Hold Off HHS Drug Negotiations

Executive Summary

Maintaining the Medicare drug price comparison website after the Part D prescription benefit begins could help hold off proposals to allow HHS to negotiate prices for the program, Centers for Medicare & Medicaid Services Senior Policy Advisor Tim Trysla told a Pharmacy Care Management Association/Health Strategies Consultancy specialty pharmacy conference in Washington, D.C. June 16

You may also be interested in...



CMS Shutdown Of Drug Pricing Site In 2006 Will Create “Chaos” – Scully

Consumers will "flip out" when the Centers for Medicare & Medicaid Services shuts down the price comparison website for drug discount cards in January 2006, former Centers for Medicare & Medicaid Services administrator Tom Scully predicts

CMS Shutdown Of Drug Pricing Site In 2006 Will Create “Chaos” – Scully

Consumers will "flip out" when the Centers for Medicare & Medicaid Services shuts down the price comparison website for drug discount cards in January 2006, former Centers for Medicare & Medicaid Services administrator Tom Scully predicts

HHS Rx Price Negotiations Could Gain Bipartisan Support, Consultant Says

Congress will move to strike down the Medicare Rx law's "non-interference" provision in the next two years, former Senate Finance Committee health advisor Kathleen Means said at the Biotechnology Industry Organization's annual conference in San Francisco June 9

Related Content

UsernamePublicRestriction

Register

PS044216

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel